Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
that's got to be worth at least $25.
a cancer vaccine for gods sake.
some people say RGBP worth nothing.
some people say RGBP worth $25.
i don't know what to believe.
why is CHNC up so much?
why isn't RGBP at least $25 a share
company develops a cancer vaccine
no one, no one, will get cancer
it's a wonder RGBP's stock price isn't $25 a share
to a large pharmaceutical co.
RGBP can sell this for billions
will be worth billions
a cancer vaccine for god's sake
on 8/17/21 RGBP filed an mRNA cancer vaccine
On August 17, 2021 the United States Patent and Trademark Office ( “USPTO”) issued Patent Number 11,090,332 B2 to Regen Biopharma, Inc. for “Antigen Specific MRNA Cellular Cancer Vaccines”.
https://www.otcmarkets.com/filing/html?id=15189224&guid=yJs9kKevTCTl9th
why is CHNC increasing so much?
why is ICOA increasing so much?
why is MNVN increasing so much?
is RGBP going to hit $1.00 today?
Microcap Daily Commentary, "Potential Merger Acquisition looming with Precigen OR another Big Pharma and if so it would make perfect sense for the following reasons. The CEO of Precigen (PGEN) Helen Sabzevari is on RGBP’s Scientific Advisory Board. PGEN trades on Nasdaq with a Market Cap of $1.3B and has an extensive clinical trials pipeline in Immunology-Oncology that includes development of mRNA vaccines therapies. https://precigen.com/about. PGEN is in the same clinical therapeutic niche market of Oncology-Immunology candidate drug development that RGBP is in. 100% identical including the same mRNA vaccine technology. It would make sense if PGEN straight up buys-out RGBP OR does a Merger Acquisition and the motive to do this is the numerous valuable Patents RGBP owns that have Billion Dollar Market Capacity. Koos is presently on an aggressive campaign to pull everything together about RGBP in the shortest amount of time to apparently ready the company for SALE! If you look closely at his recent actions it points to this." LINK HERE https://microcapdaily.com/regen-biopharma-inc-otcmkts-rgbp-biotech-sleeper-sitting-on-a-major-league-patent-portfolio/132392/
RGBP SHORTED BIG last month. They slowed down a little Friday a little over 35%. They still need to cover!
https://www.otcshortreport.com/company/RGBP
RGBP Projected Buyout Value ($5.75 - $6.25 a share) see LINK HERE
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165627226
Regen BioPharma, Inc. Patent Issued Link Here https://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/11090332
David Koos has over 30 years of investment banking and venture capital experience. He has a deep knowledge of startup businesses, public markers and SEC reporting companies. Dr. Koos has extensive relationships with large and small financial institutions, hedge funds and entities that Regen BioPharma expects to leverage for company growth.
RGBP owns a valuable patent porfolio. Regen has identified and filed patents on small molecules that activate and inhibit a novel gene (NR2F6) which controls how the immune system reacts to cancer cells and to inflammatory responses.
-- We see Koos moving to get all his expired Patents updated. Logically this move would be consistent with preparing for an acquiring company to take over the patents then turn around and file an FDA IND post buy out in order to immediately place those candidate drug Patents in their clinical trials pipeline.
-- Lastly Koos is not updating the company website that’s been outdated for years. Why would he invest time, energy, and money in updating his company website if he’s about to sell the company?
-- On April 7, 2021 KCL Therapeutics, Inc. (“KCL”) (RGBP subsidiary) entered into an agreement with Oncology Pharma, Inc. whereby KCL granted to Licensee an exclusive right and license for the development and commercialization of certain intellectual property for the treatment in humans of colon cancer for a term of fifteen years from April 7, 2021.
RGBP CEO David Koos owns 197 million shares of RGBPP, 14 million (?) shares of RGBP LINK HERE https://www.marketscreener.com/business-leaders/David-Raymond-Koos-06H0YV-E/biography/
Regen BioPharma Inc (OTCMKTS: RGBP) Mega Runner as Biotech Moves Towards “Pink Current” & Cancer Vaccine Patent Approved https://microcapdaily.com/regen-biopharma-inc-otcmkts-rgbp-mega-runner-as-biotech-moves-towards-pink-current-cancer-vaccine-patent-approved/132685/
Regen BioPharma, Inc. Patent Issued Link Here https://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/11090332
RGBP, now the number one most search stock on The Lion https://www.thelion.com/bin/forum.cgi?cmd=most_searched
TheLion.com - Forum
The Wall Street of Stock Trading and Investing Financial Community Site for Traders and Investors. Free stock quotes, news, research, message postings, stock picks, chat rooms, and financial content. Try our All In One Message Board search. Free stock picking trading portfolio and contest for all. Learn to trade from professional traders and in...
is George Sharp a GVSI custodianship?
is George Sharp a CUBV custodianship?
is George Sharp an RETC custodianship?
Projected Buyout Value ($5.75-$6.25 a share) LINK HERE
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165627226
RGBP is Pink (current) on OTC Markets' website.
RGBP-Cancer Vaccine Patent Approved LINK PLEASE??
why is volume so high?
ICOA, Kim Halvorson stock play (others MJWL, CLIS, BRZV)
ICOA, Consultant Kim Halvorson LINK HERE
Ms. Halvorson has a background in all aspects of publicly traded companies. With a twenty year history of smart and scalable investments she positions them to grow with the right capital structures and a solid corporate management team.
From early stage start ups, strategic partnerships or raising capital for her companies, she strongly represents the need for corporate compliance and transparency at every step.
She prides herself taking a interest in every company, allowing her to guide companies in compliance, mergers and acquisitions, and raising funding through Regulation Form 1-A offerings.
She has been a CEO and CFO of several publicly traded and continues to add value as a active board member for many OTC Markets listed Companies.
ICOA uploading current financials to get PINK LINK HERE
https://www.otcmarkets.com/stock/ICOA/news/ICOA-Inc-Announcing-the-Start-of-the-Process-of-Uploading-Disclosures-and-Financials-Statements-to-OTCIQ?id=315005
ICOA New Management, New Direction, New Business
ICOA twitter page https://twitter.com/new_icoacorp